Filippo Birocchi

14PUBLICATIONS
131CO-AUTHORS
Innate immunityHaematological tumoursPredictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Apr 09, 2026
Sialylated CD43 forms a glyco-immune barrier that restrains antileukemic immunity.

Jooho Chung, Mounica Vallurupalli, Sarah Noel

|Jan 27, 2026
Ruxolitinib for ciltacabtagene autoleucel-associated refractory diarrhea.

Viktoria Blumenberg, Filippo Birocchi, Angela Shih

|Dec 26, 2025
Drug-tolerant persisters and immunotherapy persister cells exhibit cross-resistance and share common survival mechanisms.

Maria Davern, Cole J Turner, Daryl Griffin

|Dec 10, 2025
Tuning CAR-T cells by targeting cancer-associated glycan in pancreatic cancer.

Sangwoo Park, Cassidy E Ho, Eli P Darnell

|Nov 18, 2025
CAR-T cell therapy targeting MUC17 in gastric tumors.

Sangwoo Park, Cassidy E Ho, Filippo Birocchi

|Nov 13, 2025
Ibrutinib and PD-1 Blockade Potentiate Mesothelin-Targeting CAR T-cell Therapy in Preclinical Models of Pancreatic Cancer.

Alexander Armstrong, Graziella van der Plancke, Sae Nishiguchi

Pageof 3

Frequent Collaborators

12 joint publications

Marcela V Maus

9 joint publications

Mark B Leick

8 joint publications

Giulia Escobar

6 joint publications

Alexander Armstrong